Imran H Iftikhar1,2, Meredith A Donley2, Jesse Mindel1, Adam Pleister1, Sheryll Soriano1, Ulysses J Magalang1. 1. 1 Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio; and. 2. 2 Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of South Carolina School of Medicine, Columbia, South Carolina.
Abstract
RATIONALE: Several studies have reported that both short and long sleep durations are associated with the metabolic syndrome, but whether a dose-response relationship exists is unclear. OBJECTIVES: We performed a metaanalysis to study the magnitude of the association between the different durations of sleep and metabolic syndrome. METHODS: We searched in the databases of PubMed, Web of Science, and Ovid (all Journals@Ovid) from inception to October 4, 2014 for cross-sectional studies where an association between metabolic syndrome and sleep duration was analyzed. MEASUREMENTS AND MAIN RESULTS: Eighteen studies with 75,657 participants were included. Daily sleep duration of 7 to 8 hours was used as the reference group. The odds ratio (OR) of having metabolic syndrome for short (<7 h) sleep was 1.23 (95% CI, 1.11-1.37; P < 0.001; I(2), 71%). The ORs for less than 5 hours, 5 to 6 hours, and 6 to 7 hours of sleep were 1.51 (95% CI, 1.10-2.08; P = 0.01), 1.28 (95% CI, 1.11-1.48; P < 0.001), and 1.16 (95% CI, 1.02-1.31; P = 0.02), respectively. The coefficient of sleep duration on log of ORs was -0.06 ± 0.02 (P = 0.02). The OR for long sleep duration was 1.13 (95% CI, 0.97-1.32; P = 0.10; I(2), 89%). CONCLUSIONS: A dose-response relationship exists between short sleep duration and metabolic syndrome. Those who report a sleep duration of less than 5 hours have a 1.5 higher odds of having metabolic syndrome. Our study does not support the notion that long sleep is associated with metabolic syndrome.
RATIONALE: Several studies have reported that both short and long sleep durations are associated with the metabolic syndrome, but whether a dose-response relationship exists is unclear. OBJECTIVES: We performed a metaanalysis to study the magnitude of the association between the different durations of sleep and metabolic syndrome. METHODS: We searched in the databases of PubMed, Web of Science, and Ovid (all Journals@Ovid) from inception to October 4, 2014 for cross-sectional studies where an association between metabolic syndrome and sleep duration was analyzed. MEASUREMENTS AND MAIN RESULTS: Eighteen studies with 75,657 participants were included. Daily sleep duration of 7 to 8 hours was used as the reference group. The odds ratio (OR) of having metabolic syndrome for short (<7 h) sleep was 1.23 (95% CI, 1.11-1.37; P < 0.001; I(2), 71%). The ORs for less than 5 hours, 5 to 6 hours, and 6 to 7 hours of sleep were 1.51 (95% CI, 1.10-2.08; P = 0.01), 1.28 (95% CI, 1.11-1.48; P < 0.001), and 1.16 (95% CI, 1.02-1.31; P = 0.02), respectively. The coefficient of sleep duration on log of ORs was -0.06 ± 0.02 (P = 0.02). The OR for long sleep duration was 1.13 (95% CI, 0.97-1.32; P = 0.10; I(2), 89%). CONCLUSIONS: A dose-response relationship exists between short sleep duration and metabolic syndrome. Those who report a sleep duration of less than 5 hours have a 1.5 higher odds of having metabolic syndrome. Our study does not support the notion that long sleep is associated with metabolic syndrome.
Authors: Josiane L Broussard; David A Ehrmann; Eve Van Cauter; Esra Tasali; Matthew J Brady Journal: Ann Intern Med Date: 2012-10-16 Impact factor: 25.391
Authors: Marissa A Bowman; Katherine A Duggan; Ryan C Brindle; Christopher E Kline; Robert T Krafty; Julian F Thayer; Martica H Hall Journal: Sleep Med Date: 2019-02-16 Impact factor: 3.492
Authors: Ana Amélia Benedito-Silva; Simon Evans; Juliana Viana Mendes; Juliana Castro; Bruno da Silva B Gonçalves; Francieli S Ruiz; Felipe Beijamini; Fabiana S Evangelista; Homero Vallada; Jose Eduardo Krieger; Malcolm von Schantz; Alexandre C Pereira; Mario Pedrazzoli Journal: PLoS One Date: 2020-09-18 Impact factor: 3.240
Authors: Thaise C Mondin; Amanda L Stuart; Lana J Williams; Felice N Jacka; Julie A Pasco; Anu Ruusunen Journal: Eur J Nutr Date: 2018-03-07 Impact factor: 5.614
Authors: Jennifer L Steel; Hannah Cheng; Ritambhara Pathak; Yisi Wang; Jessica Miceli; Carol Lynn Hecht; Denise Haggerty; Shyamal Peddada; David A Geller; Wallis Marsh; Michael Antoni; Reyna Jones; Thomas Kamarck; Allan Tsung Journal: Psychooncology Date: 2019-07-08 Impact factor: 3.894
Authors: Jennifer L McQuade; Sarah Prinsloo; David Z Chang; Amy Spelman; Qi Wei; Karen Basen-Engquist; Carol Harrison; Zonghao Zhang; Debra Kuban; Andrew Lee; Lorenzo Cohen Journal: Psychooncology Date: 2016-09-20 Impact factor: 3.894